Apr 26, 2024
1:75
For every 75 shares held, investors received 1. The price per share adjusted from $0.08 to $0.00.
The split itself did not change the total investment value.
Avenue Therapeutics, Inc. (ATXI) trades on the Other OTC in the Biotechnology industry.
Avenue Therapeutics, Inc. company overviewThe latest split shown was on April 26, 2024. It was a 1-for-75 reverse split, so shareholders received 1 share for every 75 they held.
This history records 2 reverse splits between September 23, 2022 and April 26, 2024.